JANSSEN BIOTECH, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1979-01-01

Employees: 10K

Market Cap: -

Website: http://www.janssenbiotech.com

Clinical Trials

Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

Completed

Conditions: Inflammatory Bowel Disease

Interventions: Other: No intervention

First Posted Date: 2008-04-15

Last Posted Date: 2017-09-06

Lead Sponsor: Janssen Biotech, Inc.

Target Recruit Count: 370

Registration Number: NCT00658827

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Active, not recruiting

Conditions: Crohn's Disease
Ulcerative Colitis
Indeterminate Colitis
Inflammatory Bowel Diseases

Interventions: Biological: Anti TNF therapy including infliximab
Drug: No Biologics

First Posted Date: 2008-02-01

Last Posted Date: 2024-12-06

Lead Sponsor: Janssen Biotech, Inc.

Target Recruit Count: 4970

Registration Number: NCT00606346

The Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry

Completed

Conditions: Crohn's Disease

Interventions: Other: No intervention

First Posted Date: 2007-11-04

Last Posted Date: 2013-03-04

Lead Sponsor: Janssen Biotech, Inc.

Target Recruit Count: 6273

Registration Number: NCT00553176

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy